Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
09-11 April, 2025
Not Confirmed
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Not Confirmed
Not Confirmed
01-02 April, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
09-11 April, 2025
Industry Trade Show
Not Confirmed
31 March-01 April, 2025
Plastics Recycling EUPlastics Recycling EU
Industry Trade Show
Not Confirmed
01-02 April, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/molecular-glue-degraders-lilly-abbvie-sign-billion-dollar-deals-bms-leads-with-three-late-stage-drugs
25 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ryvu-therapeutics-announces-strategic-reorganization-to-extend-the-cash-runway-for-the-development-of-rvu120-and-the-preclinical-pipeline-302384585.html
12 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ryvu-therapeutics-provides-an-update-on-rvu120-phase-ii-program-302330063.html
05 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ryvu-therapeutics-announces-dosing-of-the-first-patient-in-the-potami-61-phase-ii-study-of-rvu120-for-the-treatment-of-patients-with-myelofibrosis-mf-302323665.html
07 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ryvu-therapeutics-reports-2024-q3-financial-results-and-provides-corporate-update-302298774.html
29 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ryvu-therapeutics-to-collaborate-with-ncage-therapeutics-on-the-development-of-a-next-generation-adc-platform-302289898.html
23 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ryvu-therapeutics-presents-clinical-and-preclinical-data-on-rvu120-rvu305-and-novel-synthetic-lethality-programs-at-the-2024-eortc-nci-aacr-symposium-302284548.html
ABOUT THIS PAGE